Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Alanine aminotransferase
1
Effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease: Clinical implications
7/11/2024 8:47:17 AM |
Browse: 46 |
Download: 48
2
Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology. Long life to the old biomarker !
6/25/2024 10:41:21 AM |
Browse: 43 |
Download: 56
3
Risk factors and optimal predictive scoring system of mortality for children with acute paraquat poisoning
5/24/2022 2:32:32 PM |
Browse: 254 |
Download: 659
4
Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients
1/25/2022 9:22:03 AM |
Browse: 466 |
Download: 794
5
Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter?
12/27/2021 5:24:00 AM |
Browse: 324 |
Download: 596
6
Liver dysfunction as a cytokine storm manifestation and prognostic factor for severe COVID-19
12/27/2021 5:24:00 AM |
Browse: 337 |
Download: 558
7
Non-alcoholic fatty liver disease, diabetes medications and blood pressure
10/13/2021 8:37:10 AM |
Browse: 299 |
Download: 650
8
Post COVID-19 infection: Long term effects on liver and kidneys
7/12/2021 10:23:46 AM |
Browse: 439 |
Download: 721
9
Progressive liver injury and increased mortality risk in COVID-19 patients: A retrospective cohort study in China
3/3/2021 10:02:01 AM |
Browse: 457 |
Download: 1070
10
Effects of proprotein convertase subtilisin/kexin type-9 inhibitors on fatty liver
12/18/2020 5:58:43 AM |
Browse: 678 |
Download: 1187
11
Abnormal liver function tests associated with severe rhabdomyolysis
3/14/2020 3:03:29 PM |
Browse: 801 |
Download: 860
12
Liquid biopsy for non-invasive assessment of liver injury in hepatitis B patients
8/7/2019 7:09:17 AM |
Browse: 698 |
Download: 1183
13
SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review
2/18/2019 3:14:49 AM |
Browse: 890 |
Download: 1547
14
Declining diagnostic accuracy of non-invasive fibrosis tests is associated with elevated alanine aminotransferase in chronic hepatitis B
10/26/2018 2:57:35 PM |
Browse: 1043 |
Download: 1726
15
Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase
8/19/2017 11:33:54 AM |
Browse: 984 |
Download: 1665
16
Enzyme pattern of biliary colic: A counterintuitive picture
12/27/2016 8:31:00 AM |
Browse: 1006 |
Download: 1774
17
Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B
5/4/2016 10:08:00 AM |
Browse: 1065 |
Download: 1988
18
Increased liver markers are associated with higher risk of type 2 diabetes
6/29/2015 4:40:00 PM |
Browse: 891 |
Download: 1486
19
Determination of the upper cut-off values of serum alanine aminotransferase and aspartate aminotransferase in Chinese
3/1/2015 11:51:00 AM |
Browse: 1123 |
Download: 1475
20
Factors associated with significant liver fibrosis assessed using transient elastography in general population
1/27/2015 3:33:00 PM |
Browse: 1093 |
Download: 1435
21
Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels
9/16/2014 1:19:00 PM |
Browse: 926 |
Download: 947
22
Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh
9/10/2014 3:50:00 PM |
Browse: 1061 |
Download: 824
23
Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues
8/26/2014 1:51:00 PM |
Browse: 897 |
Download: 955
Page 1 of 1 ( 23 items )
<<
1
>>
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345